352 related articles for article (PubMed ID: 32279539)
1. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
Arnold SV; Bhatt DL; Barsness GW; Beatty AL; Deedwania PC; Inzucchi SE; Kosiborod M; Leiter LA; Lipska KJ; Newman JD; Welty FK;
Circulation; 2020 May; 141(19):e779-e806. PubMed ID: 32279539
[TBL] [Abstract][Full Text] [Related]
2. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
[TBL] [Abstract][Full Text] [Related]
3. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design.
Mohammedi K; Préaubert N; Cariou T; Rigalleau V; Foussard N; Piazza L; Bairras-Martin C; Couffinhal T; Bezin J; Benard A
Cardiovasc Diabetol; 2021 Mar; 20(1):63. PubMed ID: 33714278
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Ferrannini G; De Bacquer D; Vynckier P; De Backer G; Gyberg V; Kotseva K; Mellbin L; Norhammar A; Tuomilehto J; Wood D; Rydén L;
Cardiovasc Diabetol; 2021 Feb; 20(1):38. PubMed ID: 33573665
[TBL] [Abstract][Full Text] [Related]
6. Risk factor control for coronary artery disease secondary prevention in large randomized trials.
Farkouh ME; Boden WE; Bittner V; Muratov V; Hartigan P; Ogdie M; Bertolet M; Mathewkutty S; Teo K; Maron DJ; Sethi SS; Domanski M; Frye RL; Fuster V
J Am Coll Cardiol; 2013 Apr; 61(15):1607-15. PubMed ID: 23500281
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus.
Wang XB; Cui NH; Liu X; Liu X
Cardiovasc Diabetol; 2020 Feb; 19(1):22. PubMed ID: 32075646
[TBL] [Abstract][Full Text] [Related]
8. The effect of preventative cardiovascular therapies on coronary artery disease in people with and without type 2 diabetes: a propensity-matched score study.
Kiburg KV; MacIsaac AI; McCluskey GE; Sundararajan V; MacIsaac RJ
BMC Cardiovasc Disord; 2021 Sep; 21(1):463. PubMed ID: 34565341
[TBL] [Abstract][Full Text] [Related]
9. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.
; Patel MR; Dehmer GJ; Hirshfeld JW; Smith PK; Spertus JA; ; Masoudi FA; Dehmer GJ; Patel MR; Smith PK; Chambers CE; Ferguson TB; Garcia MJ; Grover FL; Holmes DR; Klein LW; Limacher MC; Mack MJ; Malenka DJ; Park MH; Ragosta M; Ritchie JL; Rose GA; Rosenberg AB; Russo AM; Shemin RJ; Weintraub WS; ; Wolk MJ; Bailey SR; Douglas PS; Hendel RC; Kramer CM; Min JK; Patel MR; Shaw L; Stainback RF; Allen JM; ; ; ; ; ; ; ;
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):780-803. PubMed ID: 22424518
[TBL] [Abstract][Full Text] [Related]
10. Coronary Artery Disease and Type 2 Diabetes Mellitus.
Naito R; Miyauchi K
Int Heart J; 2017 Aug; 58(4):475-480. PubMed ID: 28717115
[TBL] [Abstract][Full Text] [Related]
11. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk.
Jansen H; Loley C; Lieb W; Pencina MJ; Nelson CP; Kathiresan S; Peloso GM; Voight BF; Reilly MP; Assimes TL; Boerwinkle E; Hengstenberg C; Laaksonen R; McPherson R; Roberts R; Thorsteinsdottir U; Peters A; Gieger C; Rawal R; Thompson JR; König IR; ; Vasan RS; Erdmann J; Samani NJ; Schunkert H
Atherosclerosis; 2015 Aug; 241(2):419-26. PubMed ID: 26074316
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Computed Tomography for Personalized Management of Patients With Type 2 Diabetes Mellitus.
Cardoso R; Dudum R; Ferraro RA; Bittencourt M; Blankstein R; Blaha MJ; Nasir K; Rajagopalan S; Michos ED; Blumenthal RS; Cainzos-Achirica M
Circ Cardiovasc Imaging; 2020 Sep; 13(9):e011365. PubMed ID: 32900225
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of silent coronary artery disease in type 2 diabetes.
Zellweger MJ
Herz; 2006 May; 31(3):240-5. PubMed ID: 16770561
[TBL] [Abstract][Full Text] [Related]
15. Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease.
Shen Y; Dai Y; Wang XQ; Zhang RY; Lu L; Ding FH; Shen WF
Cardiovasc Diabetol; 2019 Nov; 18(1):160. PubMed ID: 31733658
[TBL] [Abstract][Full Text] [Related]
16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
Endocr Pract; 2016 Jul; 22 Suppl 3():1-203. PubMed ID: 27219496
[TBL] [Abstract][Full Text] [Related]
17. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.
Patel MR; Dehmer GJ; Hirshfeld JW; Smith PK; Spertus JA
J Am Coll Cardiol; 2012 Feb; 59(9):857-81. PubMed ID: 22296741
[TBL] [Abstract][Full Text] [Related]
18. Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.
Mahé G; Aboyans V; Cosson E; Mohammedi K; Sarlon-Bartoli G; Lanéelle D; Mirault T; Darmon P
Cardiovasc Diabetol; 2024 Jun; 23(1):220. PubMed ID: 38926722
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
Thrasher J
Am J Med; 2017 Jun; 130(6S):S4-S17. PubMed ID: 28526182
[TBL] [Abstract][Full Text] [Related]
20. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
